By Nigel Somerville | Saturday 27 December 2014
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Scancell (SCLP) is a biotech stock I’ve been keen on for some four or five years. The statistics on getting new treatments through clinical trials and regulatory approvals are terrible, so we are certainly at the high-risk end of the spectrum, but I believe the risk/reward is favourable and I like the company, management, the way it behaves (important!) and the products currently being developed. Here is why.
Filed under:
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Time left: 04:37:12